{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:56:33Z","timestamp":1789019793681,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009533","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000}}],"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["314412"],"award-info":[{"award-number":["314412"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["314552"],"award-info":[{"award-number":["314552"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Visceral leishmaniasis is a vector-borne protozoan infection that is fatal if untreated. There is no vaccination against the disease, and the current chemotherapeutic agents are ineffective due to increased resistance and severe side effects. Buparvaquone is a potential drug against the leishmaniases, but it is highly hydrophobic resulting in poor bioavailability and low therapeutic efficacy. Herein, we loaded the drug into silicon nanoparticles produced from barley husk, which is an agricultural residue and widely available. The buparvaquone-loaded nanoparticles were several times more selective to kill the intracellular parasites being non-toxic to macrophages compared to the pure buparvaquone and other conventionally used anti-leishmanial agents. Furthermore, the <jats:italic>in vivo<\/jats:italic> results revealed that the intraperitoneally injected buparvaquone-loaded nanoparticles suppressed the parasite burden close to 100%. By contrast, pure buparvaquone suppressed the burden only by 50% with corresponding doses. As the conclusion, the biogenic silicon nanoparticles are promising carriers to significantly improve the therapeutic efficacy and selectivity of buparvaquone against resistant visceral leishmaniasis opening a new avenue for low-cost treatment against this neglected tropical disease threatening especially the poor people in developing nations.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009533","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T17:22:28Z","timestamp":1624987348000},"page":"e0009533","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5991-0557","authenticated-orcid":true,"given":"Rinez","family":"Thapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasish","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5304-9479","authenticated-orcid":true,"given":"Joakim","family":"Riikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimi","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6031-8913","authenticated-orcid":true,"given":"Simo","family":"N\u00e4kki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Nissinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale","family":"N\u00e4rv\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa-Pekka","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"pntd.0009533.ref001","unstructured":"World Health Organization, WHO (cited 20 Oct 2020). Available from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"key":"pntd.0009533.ref002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral Leishmaniasis","volume":"26","author":"VG Johan","year":"2012","journal-title":"Infect. Dis. Clin. North. Am"},{"key":"pntd.0009533.ref003","first-page":"4","article-title":"A Review on Biology, Epidemiology and Public Health Significance of Leishmaniasis","author":"G Dawit","year":"2013","journal-title":"J Bacteriol Parasitol"},{"key":"pntd.0009533.ref004","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2147\/IJN.S140363","article-title":"Nanostructured delivery systems with improved leishmanicidal activity: a critical review","volume":"12","author":"N Bruni","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"pntd.0009533.ref005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"M Boelaert","year":"2007","journal-title":"Nat. Rev. Microbiol"},{"key":"pntd.0009533.ref006","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","volume":"123","author":"SL Croft","year":"1994","journal-title":"Indian. J. Med. Res"},{"key":"pntd.0009533.ref007","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.etap.2012.01.005","article-title":"Study on cytotoxicity and structure\u2013activity relationship of HL-7702 cell exposed to naphthoquinones","volume":"33","author":"J Guo","year":"2012","journal-title":"Environ. Toxicol. Pharmacol"},{"key":"pntd.0009533.ref008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02243504","article-title":"Treatment of bovine tropical theileriosis with buparvaquone","volume":"22","author":"NN Sharma","year":"1990","journal-title":"Trop. Anim. Health. Prod"},{"issue":"7","key":"pntd.0009533.ref009","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2222-1808(15)60825-8","article-title":"Control of tropical theileriosis (Theileria annulate Infection in cattle) in North Africa","volume":"5","author":"M Gharbi","year":"2015","journal-title":"Asian Pac. J. Trop. Dis"},{"key":"pntd.0009533.ref010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0034-5288(18)31765-X","article-title":"Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone","volume":"39","author":"N McHardy","year":"1985","journal-title":"Res. Vet. Sci"},{"key":"pntd.0009533.ref011","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/30.6.827","article-title":"The activity of hydroxynaphthoquinones against Leishmania donovani","volume":"30","author":"SL Croft","year":"1992","journal-title":"J. Antimicrob. Chemother"},{"key":"pntd.0009533.ref012","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/jm030868a","article-title":"Synthesis, in vitro evaluation, and antileishmanial Activity of water-soluble prodrugs of buparvaquone","volume":"47","author":"A M\u00e4ntyl\u00e4","year":"2004","journal-title":"J. Med. Chem"},{"key":"pntd.0009533.ref013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jcis.2013.01.001","article-title":"Hybrid nanoparticles for drug delivery and bioimaging: Mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye","volume":"395","author":"M Xie","year":"2013","journal-title":"J. Colloid. Interf. Sci"},{"key":"pntd.0009533.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/896562","article-title":"Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes","volume":"2012","author":"J Rytk\u00f6nen","year":"2012","journal-title":"J. Nanomater."},{"key":"pntd.0009533.ref015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12633-012-9129-8","article-title":"Manufacture of mesoporous silicon from living plants and agricultural waste: An environmentally friendly and scalable process","volume":"4","author":"L Batchelor","year":"2012","journal-title":"Silicon"},{"key":"pntd.0009533.ref016","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11095-011-0611-6","article-title":"Mesoporous silicon (PSi) for sustained peptide delivery: Effect of PSi microparticle surface chemistry on peptide YY3-36 release","volume":"29","author":"M Kovalainen","year":"2012","journal-title":"Pharm. Res"},{"key":"pntd.0009533.ref017","first-page":"41","article-title":"Excipients used in lyophilization of small molecules","volume":"1","author":"A Baheti","year":"2010","journal-title":"J. Excip. Food. Chem"},{"key":"pntd.0009533.ref018","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0305004100021988","article-title":"Wilson, A. A method of calculating the integral breadths of Debye\u00acScherrer lines","volume":"3","author":"AR Stokes","year":"1942","journal-title":"Mathematical Proceedings of the Cambridge Philosophical Society"},{"key":"pntd.0009533.ref019","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/ja01269a023","article-title":"Adsorption of Gases in Multimolecular Layers","volume":"60","author":"S Brunauer","year":"1938","journal-title":"J. Am. Chem. Soc"},{"key":"pntd.0009533.ref020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/ja01145a126","article-title":"The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms","volume":"73","author":"EP Barrett","year":"1951","journal-title":"J. Am. Chem. Soc"},{"key":"pntd.0009533.ref021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpara.2003.10.011","article-title":"Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics","volume":"34","author":"A Debrabant","year":"2004","journal-title":"Int. J. Parasitol"},{"key":"pntd.0009533.ref022","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00436-002-0695-3","article-title":"A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species","volume":"88","author":"M Teixeira","year":"2002","journal-title":"Parasitol. Res"},{"key":"pntd.0009533.ref023","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.41.5.972","article-title":"Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents","volume":"41","author":"D Sereno","year":"1997","journal-title":"Antimicrob. Agents Chemother"},{"key":"pntd.0009533.ref024","doi-asserted-by":"crossref","first-page":"e81492","DOI":"10.1371\/journal.pone.0081492","article-title":"In vitro susceptibilities of wild and drug resistant Leishmania donovani amastigote stages to andrographolide nanoparticle: Role of vitamin E derivative TPGS for nanoparticle efficacy","volume":"8","author":"S Mondal","year":"2013","journal-title":"PloS One"},{"key":"pntd.0009533.ref025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1550-7408.1990.tb01147.x","article-title":"Leishmania donovani: A chemically defined medium suitable for cultivation and cloning of promastigotes and transformation of amastigotes to promastigotes","volume":"37","author":"K Kar","year":"1990","journal-title":"J. Protozool"},{"key":"pntd.0009533.ref026","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2307\/3281131","article-title":"High efficiency plating method for Leishmania promastigotes in semidefined or completely-defined Medium","volume":"69","author":"D Iovannisci","year":"1983","journal-title":"J. Parasitol"},{"key":"pntd.0009533.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/38.1.1688447","article-title":"Characterization of nonspecific esterase activity in macrophages and intestinal epithelium of the rat","volume":"38","author":"AW Stadnyk","year":"1990","journal-title":"J. Histochem. Cytochem"},{"key":"pntd.0009533.ref028","doi-asserted-by":"crossref","first-page":"A3.B.1","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan Blue Exclusion Test of Cell Viability","volume":"111","author":"W. Strober","year":"2015","journal-title":"Curr. Protoc. Immunol"},{"key":"pntd.0009533.ref029","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"S Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discov"},{"key":"pntd.0009533.ref030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jac\/dkn189","article-title":"Antileishmanial activity of nano-amphotericin B deoxycholate","volume":"62","author":"KD Manandhar","year":"2008","journal-title":"J. Antimicrob. Chemother"},{"key":"pntd.0009533.ref031","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"P Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother"},{"key":"pntd.0009533.ref032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"JQ Reim\u00e3o","year":"2012","journal-title":"Exp. Parasitol"},{"key":"pntd.0009533.ref033","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dkm303","article-title":"In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs","volume":"60","author":"T Garnier","year":"2007","journal-title":"J. Antimicrob. Chemother"},{"key":"pntd.0009533.ref034","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2217\/nnm.12.74","article-title":"Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis:in vitroandin vivostudies","volume":"7","author":"SA Costa Lima","year":"2012","journal-title":"Nanomedicine"},{"key":"pntd.0009533.ref035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.colsurfb.2015.04.013","article-title":"Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis","volume":"130","author":"MY Want","year":"2015","journal-title":"Colloids and surfaces, B, Biointerfaces"},{"key":"pntd.0009533.ref036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/nnm-2016-0325","article-title":"Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis","volume":"12","author":"G Shahnaz","year":"2017","journal-title":"Nanomedicine (London, England)"},{"key":"pntd.0009533.ref037","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10611860903115290","article-title":"In vitroevaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis","volume":"18","author":"M Nahar","year":"2010","journal-title":"Journal of drug targeting"},{"key":"pntd.0009533.ref038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/107175400455137","article-title":"Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo","volume":"7","author":"J Sinha","year":"2000","journal-title":"Drug delivery"},{"key":"pntd.0009533.ref039","first-page":"61","article-title":"Nanoliposomal buparvaquone immunomodulates Leishmania infantum-infected macrophages and is highly effective in a murine model","author":"TA Da Costa-Silva","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"key":"pntd.0009533.ref040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jac\/dkh281","article-title":"chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine","volume":"54","author":"AG Tempone","year":"2004","journal-title":"J. Antimicrob. Chemother"},{"key":"pntd.0009533.ref041","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/17425247.2014.889678","article-title":"Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improvedin vitroandin vivoeffect in leishmaniasis","volume":"11","author":"R Khatik","year":"2014","journal-title":"Expert opinion on drug delivery"},{"key":"pntd.0009533.ref042","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dks286","article-title":"Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis","volume":"67","author":"S Kansal","year":"2012","journal-title":"Journal of antimicrobial chemotherapy"},{"key":"pntd.0009533.ref043","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"AA Date","year":"2007","journal-title":"Advanced drug delivery reviews"},{"key":"pntd.0009533.ref044","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/nn901657w","article-title":"Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats","volume":"4","author":"LM Bimbo","year":"2010","journal-title":"ACS Nano"},{"key":"pntd.0009533.ref045","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1002\/jbm.a.34294","article-title":"Tailoring the biodegradability of porous silicon nanoparticles","volume":"100A","author":"NK Hon","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"key":"pntd.0009533.ref046","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejpb.2017.10.014","article-title":"Biodegradation of inorganic drug delivery systems in subcutaneous conditions","volume":"122","author":"M Kovalainen","year":"2018","journal-title":"Eur. J. Pharm Biopharm"},{"key":"pntd.0009533.ref047","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmat2398","article-title":"Biodegradable luminescent porous silicon nanoparticles for in vivo applications","volume":"8","author":"J Park","year":"2009","journal-title":"Nat. Mater"},{"issue":"8","key":"pntd.0009533.ref048","doi-asserted-by":"crossref","first-page":"e0006701","DOI":"10.1371\/journal.pntd.0006701","article-title":"Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin","volume":"12","author":"F Khadir","year":"2018","journal-title":"PLoS Negl. Trop. Dis"},{"key":"pntd.0009533.ref049","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2016.00456","article-title":"Leishmania donovani-induced increase in macrophage Bcl-2 favors parasite survival","volume":"7","author":"RK Pandey","year":"2016","journal-title":"Front. Immunol"},{"key":"pntd.0009533.ref050","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: Intelligent design to treat complex disease","volume":"23","author":"P Couvreur","year":"2006","journal-title":"Pharm Res"},{"key":"pntd.0009533.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood-brain barrier","volume":"28","author":"PR Lockman","year":"2002","journal-title":"Drug Dev. Ind. Pharm"},{"key":"pntd.0009533.ref052","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0378-5173(92)90090-O","article-title":"Poly(diethylmethylidene malonate) nanoparticles as primaquine delivery system to liver","volume":"79","author":"TKM Mbela","year":"1992","journal-title":"International journal of pharmaceutics"},{"key":"pntd.0009533.ref053","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/nano10030597","article-title":"Combating antibiotic resistance through the synergistic effects of mesoporous silica-based hierarchical nanocomposites","volume":"10","author":"RK Kankala","year":"2020","journal-title":"Nanomaterials."},{"key":"pntd.0009533.ref054","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1039\/c1nr10580a","article-title":"Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism","volume":"3","author":"J Shen","year":"2011","journal-title":"Nanoscale"},{"key":"pntd.0009533.ref055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm.12.11","article-title":"Nanomedicine against multidrug resistance in cancer treatment","volume":"7","author":"J Gao","year":"2012","journal-title":"Nanomedicine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009533","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T17:47:37Z","timestamp":1626112057000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009533"}},"subtitle":[],"editor":[{"given":"Simon L.","family":"Croft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009533","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009533","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}